520 related articles for article (PubMed ID: 17257990)
21. Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia.
Dragomer D; Chalfant A; Biniwale R; Reemtsen B; Federman M
Perfusion; 2011 Nov; 26(6):516-8. PubMed ID: 21828161
[TBL] [Abstract][Full Text] [Related]
22. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective.
Palmer GJ; Sankaran IS; Sparkman GM; Koster A; Dyke CM; Ebra G
Heart Surg Forum; 2008; 11(1):E24-9. PubMed ID: 18270134
[TBL] [Abstract][Full Text] [Related]
23. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
[TBL] [Abstract][Full Text] [Related]
24. Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery.
Merry AF
Semin Thromb Hemost; 2004 Jun; 30(3):337-46. PubMed ID: 15282656
[TBL] [Abstract][Full Text] [Related]
25. Bivalirudin.
Warkentin TE; Greinacher A; Koster A
Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
[TBL] [Abstract][Full Text] [Related]
26. Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.
McNair E; Marcoux JA; Bally C; Gamble J; Thomson D
Perfusion; 2016 Apr; 31(3):189-99. PubMed ID: 25934498
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
Baker T; Chan R; Hill F
J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A
J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890
[TBL] [Abstract][Full Text] [Related]
29. Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies.
Huebler M; Koster A; Buz S; Boettcher W; Hetzer R; Kuppe H; Dyke CM
J Card Surg; 2006; 21(3):286-8. PubMed ID: 16684064
[TBL] [Abstract][Full Text] [Related]
30. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
[TBL] [Abstract][Full Text] [Related]
31. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
[TBL] [Abstract][Full Text] [Related]
32. Bivalirudin during primary PCI in acute myocardial infarction.
Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
Kiser TH; Fish DN
Pharmacotherapy; 2006 Apr; 26(4):452-60. PubMed ID: 16553502
[TBL] [Abstract][Full Text] [Related]
34. Plasma-modified ACT can be used to monitor bivalirudin (Angiomax) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia.
Jabr K; Johnson JH; McDonald MH; Walsh DL; Martin WD; Johnson AC; Pickett JM; Shantha-Martin U
J Extra Corpor Technol; 2004 Jun; 36(2):174-7. PubMed ID: 15334761
[TBL] [Abstract][Full Text] [Related]
35. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia.
Greinacher A
Semin Thromb Hemost; 2004 Jun; 30(3):315-27. PubMed ID: 15282654
[TBL] [Abstract][Full Text] [Related]
36. The use of bivalirudin for cardiopulmonary bypass anticoagulation in pediatric heparin-induced thrombocytopenia patients.
Gates R; Yost P; Parker B
Artif Organs; 2010 Aug; 34(8):667-9. PubMed ID: 20528853
[TBL] [Abstract][Full Text] [Related]
37. Bivalirudin in off-pump coronary artery bypass graft in a patient with heparin-induced thrombocytopenia: a case report of its use.
Audette MD; Glymph DC
AANA J; 2015 Apr; 83(2):116-22. PubMed ID: 26016170
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.
Lincoff AM; Kleiman NS; Kereiakes DJ; Feit F; Bittl JA; Jackman JD; Sarembock IJ; Cohen DJ; Spriggs D; Ebrahimi R; Keren G; Carr J; Cohen EA; Betriu A; Desmet W; Rutsch W; Wilcox RG; de Feyter PJ; Vahanian A; Topol EJ;
JAMA; 2004 Aug; 292(6):696-703. PubMed ID: 15304466
[TBL] [Abstract][Full Text] [Related]
39. Bivalirudin in PCI: an overview of the REPLACE-2 trial.
Maroo A; Lincoff AM
Semin Thromb Hemost; 2004 Jun; 30(3):329-36. PubMed ID: 15282655
[TBL] [Abstract][Full Text] [Related]
40. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
